Autopsy report · NCT04174794

Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.

“COVID-19 Pandemic”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month after it had already started.
Ran for about 5 months before it stopped.
43 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: University Hospital, Geneva
Sponsor type: University, hospital or other
Conditions: Acute Heart Failure
Interventions: Lung ultrasound
Participants: 43
Sites: 1
Countries: Switzerland

Trials that died the same way

Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
“COVID pandemic” (90% match in meaning)
Dry Needling for Patients With Back Pain
“COVID-19” (87% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.